Mail

UK markets close in 3 hours 52 minutes

FTSE 100
8,201.54
+18.47(+0.23%)
FTSE 250
20,597.86
+161.52(+0.79%)
AIM
801.77
+1.50(+0.19%)
GBP/EUR
1.1748
-0.0006(-0.05%)
GBP/USD
1.2715
+0.0011(+0.09%)
Bitcoin GBP
53,459.81
+141.43(+0.27%)

Trending tickers

Salesforce, Dr Martens, Aramco and Disney

The latest investor updates on stocks that are trending on Thursday

Faron Pharmaceuticals Oy (FARON.HE)

Helsinki - Helsinki Real-time price. Currency in EUR

Add to watchlist

2.1000

-0.1000

(-4.55%)

As of 02:07PM EEST. Market open.

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	150.25M
Enterprise value	156.49M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	43.75
Enterprise value/revenue	-107.35k
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	-0.13
52-week change ³	-32.10%
S&P500 52-week change ³	24.78%
52-week high ³	4.5900
52-week low ³	1.3520
50-day moving average ³	1.9073
200-day moving average ³	2.9174

Share statistics

Avg vol (3-month) ³	117.94k
Avg vol (10-day) ³	223.61k
Shares outstanding ⁵	72.01M
Implied shares outstanding ⁶	78.42M
Float ⁸	41.83M
% held by insiders ¹	39.29%
% held by institutions ¹	12.92%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-166.16%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-28.37M
Net income avi to common (ttm)	-30.94M
Diluted EPS (ttm)	-0.4800
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	6.88M
Total cash per share (mrq)	0.1
Total debt (mrq)	13.11M
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.59
Book value per share (mrq)	-0.22

Cash flow statement

Operating cash flow (ttm)	-23.81M
Levered free cash flow (ttm)	-12.88M